Page 578 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 578

20  Endocrinology  563


             Vascular system:
             •	 Accelerated atherosclerosis (hallmark)
             •	 Gangrene and myocardial infarction
             •	 Hyaline arteriolosclerosis (amorphous hyaline thickening of the wall of the arterioles
               causing narrowing of the lumen)
             •	 Diabetic microangiopathy (diffuse thickening of the basement membrane, most evident
               in the capillaries of the skin, skeletal muscle, retina, renal glomeruli, renal tubules, pe-
               ripheral nerves and placenta)
             Diabetic nephropathy:
             •	 Microalbuminuria: Earliest manifestation of diabetes is the appearance of low amounts of
               albumin in urine (.30 mg/day but ,300 mg/day).
             •	 Glomerular lesions:
               •	 Capillary basement membrane thickening
               •	 Diffuse mesangial sclerosis
               •	 Nodular glomerulosclerosis (Kimmelstiel–Wilson	lesion;	pathognomic	of	diabetes)
             •	 Renal vascular lesions: Renal arteriosclerosis and atherosclerosis
             •	 Pyelonephritis including papillary necrosis (necrotizing papillitis)
             Diabetic ocular complications:
             •	 Retinopathy
             •	 Cataract
             •	 Glaucoma
             Diabetic neuropathy:
             Central and peripheral nervous systems are both affected. It alters both motor and sensory
               functions.
             Defective immunity:
             •	 Enhanced susceptibility to infections
             •	 Defects in neutrophilic function

             Q. Enumerate the criteria for diagnosis of DM. Enlist the investigations
             advocated in a patient of DM.
             Ans.	 	Diagnostic	criteria	for	diabetes	mellitus	are	described	in	Table 20.2.


               TABLE 20.2.   Diagnostic criteria for diabetes mellitus

               •  HbA1C . 6.5%
               •  Symptoms of diabetes plus random plasma glucose . 200 mg/dL (symptoms of diabetes plus
                 random whole blood glucose . 175 mg/dL)
                 OR
               •  Fasting plasma glucose . 126 mg/dL; fasting is defined as no calorie intake for at least 8 h (fasting
                 whole blood glucose . 110 mg/dL)
                 OR
               •  Two-hour plasma glucose . 200 mg/dL during an oral 75 g glucose tolerance test (whole blood
                 . 175 mg/dL)
                 In the absence of unequivocal hyperglycaemia or presence of acute metabolic decompensation, these criteria
                  should be confirmed by repeat test.
                 Impaired	fasting	glucose	(IFG)
               •  Fasting plasma glucose .110 mg/dL but ,125 mg/dL (whole blood glucose .100 mg/dL but
                 ,110 mg/dL)
                 Impaired	glucose	tolerance	(IGT)
               •  Plasma glucose between 140 mg/dL and 200 mg/dL, 2 h after oral glucose load (whole blood
                 glucose between 125 mg/dL, 2 h after oral glucose load)

             Determination of Blood Glucose
             •	 Glucose  concentration  is  uniform  in  water  phase  of  plasma  and  erythrocytes.  Since,
               plasma contains per unit volume 27% more water than erythrocytes, glucose levels are
               higher in a given volume of plasma than in an identical volume occupied by erythrocytes.
               For this reason, plasma glucose values are higher than whole blood glucose values.


                                  mebooksfree.com
   573   574   575   576   577   578   579   580   581   582   583